tirzepatide for heart failure Lilly's Reduced and Obesity Symptoms in Phase 3 Trial Schematic illustration of Tirzepatide's effects

Tirzepatide adds GIP agonism and reaches 22.5%

That translates to roughly 56 lb for someone starting at 231 lb

However, persistent side effects may reduce treatment adherence, slowing progress

[3] If constipation persists despite appropriate laxative use, or if symptoms worsen, medical review is warranted to exclude other contributing factors or complications

So, the scientists wanted to find a way to get FOXO4 and p53 unstuck from each other maybe then the p53 could do its job and the senescent cell would die

The FDA confirmed in February 2025 that compounded semaglutide remains legal through 503A pharmacies for patients with documented medical need (allergy, non-commercial strength, or different delivery route), but warned 30 telehealth companies against illegal marketing of compounded GLP-1s [3]